Identifying host human products responsible for natural transformation of resistance traits in Acinetobacter baumannii
鉴定负责鲍曼不动杆菌抗性特征自然转化的宿主人类产物
基本信息
- 批准号:10093070
- 负责人:
- 金额:$ 10.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-02-07 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcinetobacterAcinetobacter InfectionsAcinetobacter baumanniiAlbuminsAmino Acid MotifsAmino Acid SequenceAntibiotic ResistanceAntibioticsBacteriaBacterial Antibiotic ResistanceBacterial GenesBiological AssayBloodCandidate Disease GeneCaseinsChemicalsClinicalCodeCommunitiesCompetenceDNADataDevelopmentESKAPE pathogensFrequenciesFutureGene Expression ProfilingGene TransferGenesGeneticGenetic MaterialsGenetic ModelsGenomeGoalsGovernment AgenciesHealthHumanInfectionKnowledgeLegionella pneumophilaMedicalModelingMolecularMulti-Drug ResistanceMultidrug-resistant AcinetobacterMutationNosocomial InfectionsPeptidesPhenotypePlayProcessProteinsRNARegulatory ElementResearchResistanceResistance developmentRoleScientistSerum AlbuminSignal TransductionSourceStreptococcusStructureSystemTestingTherapeuticVibrio choleraeantimicrobialbacterial resistanceenhancing factorgenetic resistanceinsightmembermicroorganismnovel strategiespathogenpathogenic bacteriaresistance genetooltraittransmission processuptakewhole genome
项目摘要
PROJECT SUMMARY
In recent years, a massive increase in the rates of antibiotic resistant bacteria has been observed in clinical
settings, causing significant concern from both the scientific community and government agencies. Among the
pathogens causing these alarming infections is Acinetobacter baumannii, a microorganism that has developed
resistance to almost all available antibiotics. Its extreme genome plasticity, largely facilitated by horizontal
genetic transfer (HGT) processes, has contributed to its remarkable antibiotic-resistance phenotype.
Transformation seems to be a particularly important HGT mechanism in this bacterium. However, the
environmental signals triggering competence for natural transformation, the putative effectors involved in this
process, and the molecular basis of this phenomenon are still poorly understood. Using the A. baumannii A118
clinical isolate as a model, the proposed project will examine the role of human host products as chemical
inducers of DNA uptake. Considering our preliminary data, which show that different albumins cause a
significant increase in the level of transformation frequency, this study will examine the role of Human Serum
Albumin (HSA) and albumin-derived peptides in the development of bacterial competence and the uptake of
foreign DNA (Aim 1). Moreover, we will determine the effects of HSA using a whole-genome transcriptional
profiling approach in A118 (Aim 2). Through this last approach, we expect to identify genes and RNA
regulators involved in natural transformation. This knowledge will provide critical insights into the molecular and
cellular mechanism this pathogen uses to acquire resistance genes. Future studies can then use these findings
to develop novel approaches to treat severe Acinetobacter human infections, particularly those caused by
emerging multidrug-resistant isolates.
项目摘要
近年来,在临床中观察到了抗生素耐药性细菌速率的大量升高
设置,引起科学界和政府机构的重大关注。在
引起这些令人震惊感染的病原体是鲍曼尼杆菌,这是一种已经发展的微生物
对几乎所有可用抗生素的抗性。它的极端基因组可塑性在很大程度上由水平促进
遗传转移(HGT)过程有助于其显着的抗生素耐药表型。
转化似乎是该细菌中特别重要的HGT机制。但是,
环境信号引发了自然转化的能力,涉及的推定效应子
过程,这种现象的分子基础仍然很少了解。使用A. Baumannii A118
临床分离为模型,拟议的项目将研究人类宿主产品作为化学的作用
DNA摄取的诱导者。考虑到我们的初步数据,这表明不同的白蛋白导致
转化频率水平的显着增加,本研究将检查人血清的作用
白蛋白(HSA)和白蛋白衍生的肽在细菌能力的发展和吸收
外国DNA(目标1)。此外,我们将使用全基因组转录确定HSA的影响
A118中的分析方法(AIM 2)。通过最后一种方法,我们希望识别基因和RNA
参与自然转化的监管机构。这些知识将为分子和
细胞机制该病原体用于获得抗性基因。然后,未来的研究可以使用这些发现
开发新的方法来治疗严重的运动杆菌感染,特别是
新兴的多药抗性分离株。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maria Soledad Ramirez其他文献
Emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) paediatric clone among skin and soft-tissue infections in Buenos Aires.
布宜诺斯艾利斯皮肤和软组织感染中出现社区获得性耐甲氧西林金黄色葡萄球菌 (CA-MRSA) 儿科克隆。
- DOI:
10.1016/j.ijantimicag.2007.06.007 - 发表时间:
2007 - 期刊:
- 影响因子:10.8
- 作者:
M. Tokumoto;V. Ybarra;M. Torreno;Maria Del Pilar Rodriguez Rodriguez;Maria Soledad Ramirez;L. Vargas;D. Centrón - 通讯作者:
D. Centrón
Maria Soledad Ramirez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maria Soledad Ramirez', 18)}}的其他基金
Identifying host human products responsible for natural transformation of resistance traits in Acinetobacter spp
鉴定负责不动杆菌属抗性特征自然转化的宿主人类产品
- 批准号:
10656154 - 财政年份:2018
- 资助金额:
$ 10.65万 - 项目类别:
Identifying host human products responsible for natural transformation of resistance traits in Acinetobacter spp
鉴定负责不动杆菌属抗性特征自然转化的宿主人类产品
- 批准号:
10331710 - 财政年份:2018
- 资助金额:
$ 10.65万 - 项目类别:
相似国自然基金
基于体内PK/PD同歩模型的达氟沙星对鸡毒支原体、大肠杆菌混合感染防耐药突变研究
- 批准号:31702291
- 批准年份:2017
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
氧氟沙星在霉形体--大肠杆菌感染鸡的药动与药效学研究
- 批准号:39670566
- 批准年份:1996
- 资助金额:6.0 万元
- 项目类别:面上项目
大肠杆菌感染对恩氟沙星在猪体内代谢及药动学影响研究
- 批准号:39470547
- 批准年份:1994
- 资助金额:6.0 万元
- 项目类别:面上项目
相似海外基金
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 10.65万 - 项目类别:
Research Grant
Dual-Wavelength Blue Light Irradiation for Improved Treatment of Staphylococcus aureus Infections
双波长蓝光照射改善金黄色葡萄球菌感染的治疗
- 批准号:
10724476 - 财政年份:2023
- 资助金额:
$ 10.65万 - 项目类别:
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
仿生巨噬细胞膜包被的纳米海绵:一种治疗多重耐药铜绿假单胞菌和鲍曼不动杆菌医院相关肺炎的新疗法
- 批准号:
10674406 - 财政年份:2023
- 资助金额:
$ 10.65万 - 项目类别:
Dual-Stimuli Responsive Antibiotic-Loaded Nanoparticles: A New Strategy to Overcome Antimicrobial Resistance
双刺激响应抗生素负载纳米颗粒:克服抗生素耐药性的新策略
- 批准号:
10703696 - 财政年份:2023
- 资助金额:
$ 10.65万 - 项目类别:
FabI Inhibitors as Potent, Gut Microbiome-Sparing Antibiotics
FabI 抑制剂是有效的、保护肠道微生物群的抗生素
- 批准号:
10673319 - 财政年份:2023
- 资助金额:
$ 10.65万 - 项目类别: